Skip to main content
Endovascular Management of
Immature Arteriovenous Fistula
KHALID RAJHI, MD, FACS
DIU Vascular Access, Sorbonne-Université
Consultant of Vascular & Endovascular Surgery
Jazan Specialist Hospital – Jazan Health Cluster – Saudi Arabia
Hemodialysis Access Management course, Aseer, 2026
Objectives
• Understand : - Maturation
- Diagnosis
- Endovascular management
Disclosure
Global Burden
• AVF non-maturation remains common.
• Prevalence: 20% to 60% of newly created
AVFs fail to mature adequately for use.
Port J Nephrol Hypert 2021
Preoperative Planning
• Vessel Mapping: (DUS) is essential;
reduces failure rates from 35% to 8%
compared to physical exam alone.
• Minimum Diameters: Artery ≥2.0
mm; Vein ≥2.0 mm to 2.5 mm.
Hemodialysis Access - Society for Vascular Surgery
(KDOQI2019)
Factors Influencing Maturation
• Patient and vessel factors.
AVF Maturation
• Historical "Rule of 6s": 6 weeks post-
op; flow >600 mL/min, diameter >6
mm, depth <6 mm, and 6 cm length.
• 2019 KDOQI Functional Definition:
Ability to provide prescribed dialysis
with two needles for 75% of
treatments over 4 weeks.
Hemodynamic Changes
&
Biology of Maturation
• Flow augmentation,
Endothelial
adaptation and
remodeling.
AVF Anatomy
• Radio-cephalic, brachiocephalic, brachio-basilic.
Physiological vs Clinical Immaturity
Postoperative Evaluation Timeline
The 4-to-6 Week Rule: A formal physical and/or DUS
evaluation must occur 4–6 weeks post-surgery.
Visual/Auditory Clues: systolic-diastolic thrill and low-
pitched rumbling bruit indicate healthy maturation.
Red Flags: High-pitched bruits (stenosis),
hyperpulsatility (outflow obstruction), or weak thrills.
Classification
• Inflow, Arterial disease
and calcification.
• Juxta-Anastomotic
Stenosis, most common
lesion.
• Outflow, Cephalic arch
and venous lesions.
• Accessory veins
• Thrombosis.
Accessory Veins
(Competitive drainage)
• The "Steal" Problem: Large branches divert flow from the primary conduit,
dropping pressure and preventing dilatation.
• Clinical Goal: Eliminate competitive flow to divert 100% of volume into the
main outflow channel.
• Evidence: post-AVO, fistulas often mature within one month.
• Technical Option: AVO Methods
• Coil Embolization: Effective but carries a risk of migration to central
circulation or pulmonary arteries.
• Vascular Plugs (VPs): Self-expanding nitinol mesh; offers more precise
placement and lower migration risk.
• Surgical Ligation: Often preferred for acute takeoff angles where wire
selection is difficult.
Diagnostic Ultrasound (DUS) Criteria
• Significant Stenosis: >50% luminal narrowing relative
to healthy segments.
• Functional Parameters:
– Peak Systolic Velocity (PSV) ratio >2.
– PSV >400 cm/s in non-anastomotic zones.
– Persistent failure to reach blood flow (Qa​
) ≥500
mL/min.
Fistulography
Timing of Intervention
• Endovascular Salvage Window: If maturation
stalls by 6 weeks, intervene promptly (6–8
week window) to minimize CVC exposure.
• Acute Thrombosis: A critical medical
emergency; rescue is most successful within
48 hours.
• Avoid Preemptive PTA: Intervention on
asymptomatic stenosis in a
functioning/maturing AVF is NOT
recommended.
Role of Endovascular Intervention
• Objective: Mechanical correction of anatomical lesions to
facilitate physiological remodeling.
• Salvage Rates: Endovascular techniques can rescue up to 80%
of immature AVFs from primary failure.
• Advantage: Minimally invasive, outpatient-based, and
preserves future "venous capital”.
PTA
First-line therapy
• Options: Balloon-Assisted
Maturation (BAM)
• Primary Balloon Angioplasty (PBA)
Emerging technique of
intraoperative dilatation to
accelerate maturation from Day 1.
• Technical Success: Typically ranges
from 88.9% to 97%.
PTA
• Sequential Sizing: 4 mm high-
pressure balloons for juxta-
anastomotic lesions; 5–6 mm for
outflow.
• Large-Balloon Strategy: Using
balloons ≥7 mm leads to higher
maturation rates (97% vs. 88%)
and faster catheter-free HD.
Stent Grafts
• Options: Covered Stents and
Stent Grafts
• Rescue Indications:
– Persistent elastic recoil after
high-pressure PTA.
– Severe, diffuse, long-segment
stenosis (>4 cm).
– Flow-compromising venous
rupture/dissection during
BAM.
• Materials: ePTFE-lined nitinol
(e.g., Viabahn, Wrapsody).
The "Stentula" Technique
• Retrograde Placement: Stent placed
toward (but not crossing) the arterial
anastomosis.
• Strict Maturation Period: A 2-week "wait"
with antiplatelet therapy is mandatory to
allow epithelialization/fibrous
encapsulation.
• Result: The stented segment can be safely
and routinely punctured for HD access.
Juxta-anastomotic stenosis
• A 48 years old female ESRD on HD via Permcath, Left AVF
created 7 week back with weak thrill, AVF flow rate 480
ml/min.
• Managed with Cutting Balloons for Fibrotic stenosis.
Cephalic arch stenosis
• A 54 years old male ESRD on
HD via femoral Permcath,
right UE AVF created 6
months ago, interrupted HD
with prolonged hemostasis,
AVF flow rate 650 ml/min.
• Managed previously by High-
Pressure Balloon.
• For resistant lesion.
• Later on, Drug-Coated
Balloon
• Reduce restenosis.
Clinical Success
Outcomes
• Technical Success:
Reported at 95.7% to 97%
for endovascular salvage.
• Clinical Success (HD
readiness): Achieving
functional HD in 85.2% to
93.4% of salvaged cases.
Post-Intervention Patency
• 1-Year Primary Patency: Varies significantly (45.4% to 71.9%)
depending on initial lesion severity.
• 1-Year Secondary Patency: Consistently high, ranging from
82.8% to 94.8%.
• Maintenance: Functional patency often requires repeated
interventions (aim for <3 annually).
Independent
Predictors of
Salvage
Success
• Stenosis Severity: Pre-intervention
narrowing >90% is a strong predictor of
reduced durability and early restenosis.
• Lesion Type: "Mixed" stenosis
(combined inflow and outflow) is
associated with poor outcomes (HR
6.33).
• Permcath History: A history of
ipsilateral Catheter is the sole risk
factor for complete maturation failure
after BAM.